Camrelizumab in different PD-L1 expression cohorts of pre-treated advanced or metastatic non-small cell lung cancer: a phase II study
卡瑞利珠单抗在不同PD-L1表达水平的既往接受过治疗的晚期或转移性非小细胞肺癌患者中的应用:一项II期研究
期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-021-03091-3
Yang, Jin-Ji; Huang, Cheng; Fan, Yun; Pan, Hongming; Feng, Jifeng; Jiang, Liyan; Li, Xing-Ya; Liu, Xiao-Qing; Xiong, Jian-Ping; Zhao, Yan-Qiu; Cheng, Ying; Ma, Rui; Wang, Jie; Wang, Yina; Liu, Yan-Hui; Lin, Dong-Mei; Wang, Tao; Shi, Wei; Zou, Jianjun; Wu, Yi-Long